Research Publications
The latest from Maverex.
Latest Posts
Find our peer-reviewed research publications across oncology, cardiovascular, infectious disease and much more.
Rapid evidence publication in the COVID-19 era: impact on study quality and study identification
Wright C, Misso K, Green R, Marjenberg Z. Rapid evidence publication in the COVID-19 era: impact on study quality and study identification (SA43). Poster presented at ISPOR Europe; 6-9th November 2022; Vienna: Austria, 2022
Trends in clinical evidence for digital health applications (DiGa) reimbursed in the German DiGa directory
Skeldon G, Dobson J, Adkins E. Trends in clinical evidence for digital health applications (DiGa) reimbursed in the German DiGa directory. Poster presented at ISPOR Europe; 6-9th November 2022; Vienna: Austria, 2022
The increasing use of population-adjusted indirect comparisons in the NICE Health Technology Assessment (HTA) submission process and the response to these methods
Pooley N, Kisomi M, Embleton N, Langham S. The increasing use of population-adjusted indirect comparisons in the NICE Health Technology Assessment (HTA) submission process and the response to these methods (CO163). Poster presented at ISPOR Europe; 6-9th November 2022; Vienna: Austria, 2022
Reusable soft mist inhalers have an improved carbon footprint compared with dry powder inhalers and pressurised metered-dose inhalers
Janson C, Hernando Platz J, Soulard S, Langham S, Nicholson L, Hartgers-Gubbels E. Reusable soft mist inhalers have an improved carbon footprint compared with dry powder inhalers and pressurised metered-dose inhalers (HSD2). Poster presented at ISPOR Europe; 6-9th November 2022; Vienna: Austria, 2022
Treatment with dual and triple therapy in chronic obstructive pulmonary disease in line with current guidelines reduces the carbon footprint
Janson C, Hernando Platz J, Soulard S, Langham S, Nicholson L, Hartgers-Gubbels E. Treatment with dual and triple therapy in chronic obstructive pulmonary disease in line with current guidelines reduces the carbon footprint (MT40). Poster presented at ISPOR Europe; 6-9th November 2022; Vienna: Austria, 2022
Is evidence on environmental impact included in health technology assessment and does it influence decision-making?
Hubbert L, Embleton N, Wright A, Nicholson L. Is evidence on environmental impact included in health technology assessment and does it influence decision-making? (HTA56). Poster presented at ISPOR Europe; 6-9th November 2022; Vienna: Austria, 2022
Health technology assessment and reimbursement of medical devices in England, France, and Germany
Heptinstall A, Teague R. Health technology assessment and reimbursement of medical devices in England, France, and Germany (HTA243). Poster presented at ISPOR Europe; 6-9th November 2022; Vienna: Austria, 2022
What is the true burden of diphtheria, tetanus, pertussis, and poliovirus in children aged 3-18 in Asia?
Nicholson L, Adkins E, Karyanti M, Ong-Lim A, Shenoy B, Huoi C, et al. What is the true burden of diphtheria, tetanus, pertussis, and poliovirus in children aged 3-18 in Asia? A systematic literature review. Int J Infect Dis 2022;117:116-129.
Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis
Müllerová H, Marshall J, de Nigris E, Varghese P, Pooley N, Embleton N, et al. Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis. Ther Adv Respir Dis 2022;16:17534666221113647.
